Abstract
Selective constraint and pressures upon the host tissues often signifies a beneficial microbiome in any species. In the context of oral microbiome this displays a healthy microbial cosmos resisting the colonization and helps in rendering protection. This review highlights the endeavors of the oral microbiome beyond the bacteriome encompassing virome, mycobiome, protozoa and archaeomes in maintaining the oral homeostasis in health and disease. Scientific data based on the peer-reviewed publications on the microbial communities of the oral microbiome were selected and collated from the scientific database collection sites of web of science (WOS), pubmed central, Inspec etc., from 2010 to 2021 using the search key words like oral microbiome, oral microbiota, oral virome, oral bacteriome, oral mycobiome and oral archaeome. Data excluded were from conference proceedings, abstracts and book chapters. The oral homeostasis in both the health and disease conditions, mostly is balanced by the unrevealed virome, mycobiome, oral protozoa and archaeome. The review documents the need to comprehend the diversity that prevails among the kingdoms in order to determine the specific role played by each domain. Oral microbiome is also a novel research arena to develop drug and targeted therapies to treat various oro-dental infections.
Keywords: Oral microbiota, Bacteriome, Virome, Mycobiome, Archaeomes, Cross-kingdom interactions
1. Introduction
The human oral cavity encompasses a plethora of microbial community comprising of commensal, symbiotic and a conglomeration of pathogenic bacteria, fungi, archaea and parasites. These microbial cosmos in the oral cavity is referred as oral microbiota, and the term oral microbiome refers to their respective genomes [1]. The oral microbiome often signifies the ecology of the human space shared with the microbes and also is considered as the ignored determinants of systemic health and disease [2]. Oral cavity being the major gateway to the human body, can often spread the ecological and pathogenic flora to the contiguous structures progressing with systemic diseases [3]. Re-focusing on the microbial communities in the oral microbiome had revealed a consortium of organisms rather than a single microbe [4]. Oral microbiota is thus diverse and is influenced by factors like diet, oral hygiene, habitual and other environmental factors in the host. This unique diversity is associated with the number of species that are present and represented in the ecological community attributing species evenness and richness respectively [5].
A synergistic and co-operative mode of action by the microbes in concert with the host immune response renders a dynamic balance and stability for the oral microbiome and determines the progression with a disease [6]. A complete knowledge on the endogenous residents is thus necessary for a comprehensive understanding of any microbiome. This has an intrinsic limitation when the conventional microbiological protocols are considered, where only 50% of the micro-organisms are cultivable with a slew of investigations progressed in this goal [7]. Skyrocketed literatures focusing on the oral microbiome had focused more on bacteriome with lower abundant studies on the other microbiome like mycobiome, virome, archaea and parasites. With the advent of science and next generation sequencing (NGS), identification of the oral microbes had spurred renewed interest, with numerous studies sparking with oral microbiome and on dysbiotic genera [8]. Beyond the bacteriome, the other functional biomes play a pivotal role in maintaining the homeostasis of the ecological niche (Fig. 1). The lack of optimized tools limit the taxonomical identity of the same and thus the microbiome beyond bacteriome is uncharacterized lavishly.
Fig. 1.
A schematic representation of the scientific data based on the peer-reviewed publications on the microbial communities of the oral microbiome. All the data were collated from the scientific database collection sites of web of science (WOS), pubmed central, Inspec etc., from 2010 to 2021 using the search key words like oral microbiome, oral microbiota, oral virome, oral bacteriome, oral mycobiome and oral archaeome. Data excluded were from conference proceedings, abstracts and book chapters.
Recently, the dark matter of the oral microbiome has come into limelight through cutting edge scientific technologies with better understanding based on various clinical studies as summarized in Table 1. Most of the oral microbiome being uncultivable, the unique candidate phyla radiation (CPR) had revealed recently, specific “microbial dark matters” such as Saccahribacteria or TM7 in the oral cavity [9], [10]. It is efficient in establishing a highly adaptive episymbiotic interactions in complicated niche like oral cavity through their specific arginine deiminise system [11], [12]. Additionally, notable members of the potent virome, mycobiome, archaea and parasites are creeping in recent literatures in the context of oral microbiome urging more population based evaluations to underpin their specific roles. It is also an avid scenario that the existence of the microbiome beyond the bacteriome accounts for inter-kingdom networks and also in host-microbe interactions [13], [14]. This review thus proposes the commandeered role and keys insights on the oral microbiome on their impact with oral and systemic health.
Table 1.
Summary of the few significant studies on the oral microbiota comprising the bacterial, viral and fungal biota.
Type of microbiota | Samples | Type of Analysis | Reads/contigs/Sequences | Reference |
---|---|---|---|---|
Bacteria | 4154 | SGB (kSGBs and uSGBs analysis) | Assembled: 56,213, average 14,094 contigs/sample, taxonomically assigned: Saccharimonadaceae (17.99%), Campylobacteraceae (9.51%) Streptococcus (12.88%) and Campylobacter (7.65%), | [98] |
25 | RDP, LCA, MySQL, ITS, LCA and phymmBL | Assembly reads 1103 contigs | [99] | |
41 | QIIME, OUT | 17,129 reads per sample; 702,304 sequences | [100] | |
747 | HOMD, TORQUE | 35,000 clone sequences | [101] | |
44 | PCoA, SOAPaligner 2.1, SOAPdenovo | 27.8% ± 16.7% sequences/reads; 49.8% ± 3.8% of the reads/sample | [102] | |
88 (31 confirmed patients with COVID-19, 29 flu patients with influenza B, and 28 healthy controls) |
Kraken2 v2.0.9, QIIME 2, MEGAHIT | Assembled contigs 3356–842,961 bp/sample Veillonella sp. (22.7%), Streptococcus sp. (20.3%), Prevotella sp. (7.1%), Acinetobacter sp. (5%), Megasphaera sp. (4.21%), Actinomyces sp. (4.19%), Atopobium sp. (3.65%), Klebsiella sp. (3.25%), and Solobacterium sp. (2.07%) |
[103] | |
Viral | 88 | FGenesV/ BLASTX homology/Qiime | Contig (16% ± 4.2% - 60 days) - 69.9% ± 5.5% versus 30.1% ± 5.5% - 7th day) | [104] |
04 | VirSorter/ vConTACT v.2.0 | Novel phages (0–7(0–44%) – 3–26 (12–46%) Novel prophages (25–54 (42–59%)− 73–323 (56–77%) |
[105] | |
05 | FGenesV | 27 429 nucleotides, 1421 reads, | [21] | |
15 | vSAGs (Illumina Tech), ProDeGe | MiSeq sequencer (2 × 250, pair-end); Reads ≥ 70% identity, ≥ 70%, viruses with ≥ 40% coverage | [28] | |
Fungi | 20 | Internal transcribed spacer (ITS),ITS1 & 2, AFTOL, WASABI, aligned (KALIGN) | 39,226 sequence; 1702 sequences per sample/ average length of 248 bases | [32] |
30 | Internal transcribed spacer (ITS), ITS1-F/ITS2, QIIME | QIIME/UNITE: 8607,862 reads; OTU- α-diversity (13,000 sequence reads/sample) (Total: 8943 OTUs sequence/read) |
[106] | |
18 | ITS | Merged sequences 712 295 MiSeq: 1 580 028 reads |
[107] | |
17 | ITS (ITS2 & 4) | MiSeq – 250 bp length; R/phyloseq:10,000 sequences per sample; 37,119 sequences |
[108] |
2. Oral virome
In numerous ecosystems, viruses are considered as the significant drivers of the diverse niche in the planet and also on the human tissues. Oral virome is considered as a robust ecosystem present as prominent indigenous members with an ability to infect the host cells as well as other bacterial cells altering the oral health condition (Table 2). Saliva encompasses approximately 108 viral particles/ml with bacteriophages as stable community for longer periods [15]. In the oral microbiome, the huge virome size and constraints on the unavailability of the genome data in NCBI databases, limits the identification of the oral virome. However, recent bioinformatics tools such as Metavir, VIROME, ACLAME, Virus seeker, Phage seed etc., it is now possible to render more evaluations on the oral viromes [16]. Analysis on the oral DNA of the virome had revealed a majority of bacteriophages under the family of Siphoviridae and Myoviridae. Oral virome also shows an abundance of phageomes against Streptococci together with members of Herpes viridae family under the eukaryotes [17]. The human oral cavity also shows a substantial number of orphan viruses that belongs to the family of Anelloviridae [18]. Thus in the present time, our analytical capabilities have increased enormously due to the availability of multiple annotated databases of the virome sequences.
Table 2.
Summary of the few significant oral virome in healthy and infectious conditions.
Model | Sample | Type of infection | Study type | Findings | References |
---|---|---|---|---|---|
Children | Saliva | Food and Mouth Diseases, Mouth ulcer | Young children (n = 55) | Bacteriophages (n = 27, 67.5%) vertebrate viruses (n = 11, 27.5%) and plant viruses (n = 2, 5%) | [30] |
Human | Saliva, Sub gingival & Supragingival plaque, Control (healthy adults) | Periodontal diseases and healthy mouth | n = 16 (Chronic severe generalized periodontitis (n = 7) and good periodontal health n = 9). | Siphoviridae Myoviruses Podoviridae |
[100] |
Young adults | Oral rinse | Healthy individuals | Young adults (n = 72) | Bacteriophages (Siphoviridae and Myoviridae, and Streptococcus phages) Viral (Herpes viridae) Caudovirales, Siphoviridae (71 samples) and Myoviridae (68 samples), Streptococcus phages (up to 69 samples), Eukaryotic viruses (Herpes viridae family (65 samples), Human herpes virus 7 (from 61 samples out of the 72 samples) |
[17] |
Volunteer’s | Salivary sample | good overall periodontal health individuals | n = 15 | Prophage (Streptococcus phages), Caudovirales | [28] |
Oral cavity Patients | Oral rinse | Patients admitted in the hospital with oral cavity diseases | n = 124 patients (Male: n = 48 Female: n = 76) | Human papilloma virus (HPV)16 – Male: N-38 and Female: N-56 | [109] |
Infants | Oral swab | HIV infected women and Non HIV infected women | n = 32 | Identified: Cytomegalovirus | [110] |
Oral virome seem to be persisters in the oral cavity and not always a transient flora as evidenced by a study in a cohort population conducted for a 60 days period and its persistence is significantly associated with sex and highly personalized [19]. Also, oral virome shows significant variations in the viral community as analyzed from the plaque sample from periodontitis in comparison with the healthy individuals. These seem to be the major predators of bacteria influencing the oral health status [20].
2.1. Oral phageoms
Interestingly, among the viruses, bacteriophages seem to be predominant in the oral microbiome based on an analysis of the virome reads from the saliva of human subjects [21]. Preponderance of shared homologs and unique differences when compared to gut phages substantiates the role of the host habitat in shaping the viruses and transforming them to be more specific in the oral habitat. These oral phages possess a prominent lysogenic cycle with functional genes and also serve as reservoirs of virulent genes especially drug resistant determinants. Substantial breach in the oral mucosal layers allows the entry of viruses in bloodstream as evidenced by viremia in humans with weakened immune system. In systemic illness like schizophrenia, metagenomic analysis shows huge variations in the oral phageoms when compared to the healthy controls [22]. In addition, oral phageomes are distinct in shaping the bacterial ecosystem of the oral cavity, as well.
A fascinating concept of “intra-body phageome” that emphasizes the role of phages in the classical sterile regions of the body is also proposed recently [23]. Analysis on the viromes and the CRISPR content suggests that, the humans sharing a particular environment or a habitat determine the robust virome community in the oral cavity [24]. In addition, the oral phageomes are also shared frequently among the households and are thus distinct among the individuals in a common household habitat. However, the alpha and beta diversity on the same shows no significant association with the gender of the human population. This suggests that, the alteration in viral ecology may be the significant indicators of disease status, which has to be monitored by the advanced molecular techniques. Albeit, with not much alteration in the viral diversity is observed, these phageoms seem to express an inexorable expansion of putative antibiotic resistant genes [25]. Amidst these genes, oral phageomes are also known to carry several specific genes with complement and antibody degrading functions together with platelet binding properties rendering benefits for their hosts [26].
2.2. Oral viromes in health and diseases
The phageomes in the oral cavity are more involved with the periodontal diseases and significantly alters the bacteriome based on the severity of the disease leading to dysbiosis and further transition promoting the oral disease [27]. Single viral genomes (SVGs) of uncultivable viruses reveal the presence of abundant viruses infecting Streptococcus followed by Actinomyces phage exhibiting their role in oro-dental diseases [28]. In periodontitis, the diversity of oral virome, analyzed via the shot gun sequencing method documents the widening of the PDL space in association with other polymicrobial infections by periodontal pathogens [29]. Genomic analysis together with the clinical findings thus suggests the implications of oral virome in influencing the biomechanical properties involved in the periodontal tissues leading to periodontitis. Investigations on the ecological niche of the patients affected with hand foot and mouth disease showed nine discriminative viral species with elevated levels of Streptococcus sp.,. It also correlated with the presence of Enterovirus and Coxsackievirus A5 and A6 together with the altered virome profiles [30]. On the other hand, a healthy human microbiome may be always accustomed with the direct health of the human body. The unexplored dark virome of the oral microbiome may also be a good indicator of health and is often associated with the adverse outcomes of vital diseases as well [31]. Composition, assembly and the dynamics are highly mosaic among the viromes, playing a vital role in the host-virome interactions of the human diseases.
3. Oral mycobiome
The oral cavity also possesses various fungal communities that are commonly referred as mycobiome and are also termed as mycobiota, fungeome or mycome. The basal mycobiome of the oral cavity comprises Candida as the frequent community, followed by Cladosporium. 50% of the oral mycobiome constitutes of Aureobasidium and Saccharomycetales. The lowest flora of fungi belongs to Aspergillus, Fusarium and Cryptococcus [32]. Several reports in recent years have detailed the importance of fungi within the oral cavity in studies involving human and animal (Table 3). Interrogation of the fungal taxa in the oral cavity also had documented nearly 74 fungal species as cultivable and 11 species under non-cultivable genera. A strong taxonomic shift was also documented in the dental mycobiome with a total of 139 fungal species with 32 differentially abundant taxa, an unclassified Microdochium species with 12 taxa that correlates with the health [33]. Analyses on the salivary mycobiome encompass Candida mycotype and Malassezia mycotypes as two ecologically distinct mycotypes warranting these as significant biomarkers for oral diseases [34].
Table 3.
Significant role of oral mycobiome in causing infections in human, immune-compromised patients and animals.
Model | Sample | Study type | Findings | References |
---|---|---|---|---|
Participants from Kips Bay Endoscopy Center in New York City | Oral wash | n = 30 (Age between 18 years or older (29–86)) | > 86.5% phyla were identified as Ascomycota and < 3.1% were identified as Basidiomycota, Glomeromycota and Chytridiomycota. Identified: Candida and Aspergillus sp. (100%), Penicillium sp. (97%), Schizophyllum sp. (93%), Rhodotorula sp. (90%), and Gibberella sp. (83%) |
[108] |
Healthy Individuals | Oral rinse | n = 20 (Age: >18, non-smoking, no symptoms of oral mucosal diseases and no recent use of antifungal agents) | Cladosporium (65%), Aureobasidium (50%), Saccharomycetales (50%), Aspergillus (35%), Fusarium (30%), and Cryptococcus (20%). | [32] |
HIV Infected and Uninfected participants | Oral rinse | n = 24 (HIV infected – 12 and Uninfected individuals – 12, Age: >18 years) |
Candida albicans (58% in uninfected and 83% in HIV-infected participants). | [111] |
Australian children | Dental plaque | n = 17 (age: 7–10 year) | Phyla were identified: Ascomycota, Basidiomycota, Zygomycota, Ascomycota, Basidomycota Taxa identified: C. albicans (12%), Naganishia diffluens (8%), R. mucilaginosa (8%) and M. globosa (6%) |
[108] |
ANIMAL BASED STUDIES | ||||
Dog | Swab | n = 51 (with and without Periodontal diseases). | Most predominant fungal species were identified: Cladosporium sp (n = 46), Malassezia restricta (N = 44), and M. Arunalokei (N = 36). | [112] |
Cat | Swab | n = 14 (Healthy cat), FCGS affected cat (n = 14) | Taxa were identified: Malassezia restricta, Cladosporium penidielloides, M. arunalokei and Aspergillaceae sp. New species identified: Bergeyella zoohelcum |
[113] |
Fungal component of the oral cavity, being in low proportion, oral mycobiome based studies often rely on internal transcribed spacer (ITS) based amplicon analysis. However, critical appraisal on these ITS based fungal diversity studies detects> 100 fungi signifying Candida as the predominant species [35]. Interestingly, over the first month of life in infants, the mycobiome profiles are variable and seem to be more similar in comparison with the vaginal mycobiome and are found to be altered upon age [36]. Similarly it is also varying in community-dwelling elderly population showing significant alterations in candidal species [37].
3.1. Alterations in the oral mycobiome
The mycobiome of the oral cavity is specifically altered by various factors, such as administration of certain drugs. An effective antifungal drug nystatin is known to affect the colonization by Candida thereby influencing the risk of biofilm formation by other potent bacterial pathogens [38]. Disease conditions may alter the oral mycobiome profiles as documented from various studies. Mycobiome profiles in children with and without caries showed an extremely low profile of fungal loads and extremely a higher prevalence of C. albicans respectively. Malassezia globosa was significant in caries free subjects primarily suggesting the role of mycobiome profiles in disease and disease-free conditions [39]. Alterations in the oral mycobiome is also evidenced in conditions with atopic dermatitis, leukemia and in immuno-compromised patients like HIV, with C. albicans in abundance in all the cases and PCR seem to be the best method to analyze the mycobiomes in comparison with the conventional methods [40]. Mycobial diversity was also evidenced in the sub-gingival plaque specimens in patients under ART therapy, with high levels of Candidal species and significantly low levels of Exseohilum sp., Guehomyces sp., Debaryomyces sp., together with three unidentified fungi [41]. A global snapshot on the alterations in the oral mycobiome in relation to the bacteriome is also documented in genetic associated disorder like Down’s syndrome [42].
It is also fascinating to note that there could be a significant alteration in the mycobiome based on the postnatal acquisition either from maternal source or from an environmental source. However, a systematic review documents that during the early life period, vaginal delivery may promote oral yeast colonization with maternal breastfeeding not showing a significant influence on the oral mycobiome [43]. Poly-microbial interactions in association with the environmental fungi may also lead to antagonistic or synergistic effect in the oral mycobiome exhibiting similarities between the host and the environment [44]. A gargantuan diverse mycobiome was functionally deciphered through next generation sequencing platforms and shows significant variations in both health and disease [45]. In this line, a pronounced mycobiome shift and fungal dysbiosis is demonstrated in patients with recurrent aphthous stomatitis with negative correlation with the occurrence of bacteriome [46]. Demonstration on the significant changes in the core oral mycobiome in HIV infected cases was observed and is independent with that of the age and sex variables leaving an impact of fungal community among the same [47]. The role of mycobiome is highly specified to be associated with colorectal cancers portraying the importance of its presence and dysbiosis in the oral cavity in relation to the gut microbiome as well [48].
4. Oral archaeome
The microbiome of the oral cavity comprises of archaeome as a third domain of cellular life and exhibits less diversity and is highly plausible as secondary colonizers. Elucidation of its importance in the oral cavity is a herculean task, as it is difficult to cultivate. It is thus evident to document its presence through PCR by detecting the specific functional genes coding for the methyl co-enzymes as most of the archaeomes fall under the category of methanogenic organisms [49]. However, the detection of archaeome, in most of the cases depends on the composition of the primer pairs and often the universal primers fail to evaluate the diversity of the archaeal signatures from the oral and also from holobiotic samples [50]. The full spectrum of archaeome is not yet elucidated due to the impediment of the bacteria targeting protocols being inapplicable for this process. Search on oral archaeome evidenced a moderate category where 4 domains of archaea correlated in inducing periodontitis with the cultivable archaea as Methanobrevibacter oralis [51] and M.oralis HOT 815 as uncultivable species under the phylum Euryarchaeota (Bringuier). M. oralis is also reported as the frequent archaeome in relation to periodontal infections [52].
Among the oral microbiome, nearly 5% of the subgingival metagenome mass revealed the presence of archaeome together with viruses and fungi analyzed through metagenomic shot gun sequencing [53]. In comparison with the healthy mucosa, Archaea were observed in patients with dental caries and also in the various oral niches from the individuals from different geographical locations implicating their role in oro-dental diseases. A better comprehension in evaluating the human oral archaeome is hampered due to methodological limitations. Contrasting results were observed in studies among healthy population, where few studies showing its absence and few other studies showing its presence in healthy population respectively [54], [55], [56]. In patients with peri-implantitis, Methanobrevibacter and Methanobacterium were reported from the study subjects from Brazil [57], but however, no significant variations from the French populations.[58] Ethnicity and dietary factors thus seem to influence the archeal signatures and often they are considered as ordinary members of sub-gingival biofilms [59]. Archaea were also associated with patients with pericoronitis erupting molars and detected exclusively in a study [60].
In the endodontic sites, M. oralis and M. smithii were more prevalent inside the root canals [61] and a positive correlation is observed between the methanogens and the Synergistes spp.,.[62]. A recent document explores the presence of the phylum Thaumarcheota in both caries and caries free healthy subjects [63]. Presence of archaeomes and “Archaea effect” is been documented from various archaeological samples/sites [64] and includes 4 specific archaeal classes such as Halobacteria, methanogenic archaeomes and Thaumarchaeota [65]. Among the methanogens, Methanobrevibacter massiliense, Methanoculleus bourgensis and Methanomassiliicoccus phylotypes were observed in dental calculus archeological samples during 15th century showing much diversity as well [66].
5. Oral parasites
The polymicrobial consortium of the oral microbiome also encompasses the protozoans as typical members in the dental plaques and in the periodontal pockets. Little has been revealed on the presence of the oral protozoa and about its commensalism in the oral microbiome. NGS based exploration of oral protozoa was a failure, however, their role is been identified only through the microscopic methods [67]. Electron microscopic studies reveal the presence of Entamoeba gingivalis (E. gingivalis) and Trichomonas tenax (T. tenax) and free living amoebae in many cases with and without diseases. Its presence is influenced by the host factors showing a mixed composition together with its prominent role along with bacteria and fungi [68]. In patients with genetic diseases, a highest prevalence of E. gingivalis and T. tenax is observed among the age group of 41–50 years portraying its role in the oral microbiome and in inducing diseases upon the alteration of the homeostasis [69].
Studies from 19th century also do document the presence of these two organisms in abundance and in highest frequency and increased endemia in a direct proportion of OHIS index. In periodontal deep pockets, a 3-fold increase in T.tenax was observed and E.gingivalis at an increased rate in case of gingivitis [70]. These organisms had been proven to be potent pathogens among the oral microbiome, capable of lysing the mucosal epithelial barriers and ingesting the RBC’s and the nuclear components of the lymphocytes as well [71]. Though the potential correlations were much discussed, the synergistic and the commensalism roles of the oral protozoa is yet an unexplored arena which might aid in future therapeutic arguments.
6. Inter-kingdom interactions among the oral microbiome
Dense colonization of the oral microbiome in the intense niche compels each microbial kingdom to be more competitive for their survival in the oral cavity, in search for space and nutrients. Advancements in the omics approach render a better understanding between the inter-kingdom interactions. Like the environmental ecosystems, the oral microbiome is highly dynamic and mosaic and are known to interact by the cross-kingdom relations (Fig. 2). This intricate interactions between the microbe and the host, influences the host response in maintaining a proper balance and homeostasis. It is also evident that an interdependent balance is essential in the maintenance of oral health and any imbalance between the kingdoms may give rise to oro-dental infections [72].
Fig. 2.
Cross-kingdom interactions between the various members of different kingdoms. Specific attachment of the different microbial community on to the specific receptor sites on the oral mucosa interact with each other for their survival, nutrients, metabolism, energy production, modulating the immune system and in maintaining the oral homeostasis both in oral health and disease.
Oral bacteria, bacteriophages and the mammalian immune system are highly inter-linked in exhibiting an efficient immune response upon the oral infections. Many models have been predicted to evaluate the role of the complex and dynamic interactions between the phageomes and bacteria in the oral cavity. It is hypothesized that a mutual benefit exists between the bacteria and the phages through the interaction of the phages via the mucosal surface leading to bacterial adhesions. A commensalism may thus prevail between them through additional binding sites for the bacteria elevating the frequency of colonization [73]. The cross-relations between archaea and aerobic bacteria promote a protective effect against the aerobic methanogens allowing them to thrive in aerobic niches of the oral cavity [74]. Aerobic bacteria also provide a micro-aerophillic environment for the Methanobrevibacter species to thrive [75]. Presence of sulphur reducing bacteria permits the growth of methanogenic archaeome to grow around the periodontal tissues with reduced co-occurrence in later stages of the disease [76]. This shows the role of the cross-relations between the kingdoms in the oral cavity in the establishment of oral health and disease. Similar positive correlations between archaeome and the anaerobic bacteria Tannerella forsythia, Porphyromonas sp., and Prevotella sp., also occur in conditions of chronic periodontitis with 10-fold increase in the numbers of M. oralis [77].
The cross-relations between bacteria and fungi is accomplished by a direct fungal-bacterial cellular interactions and the survival is assisted by the products of bacteria through metabolic interactions or alternatively by varying the host immune response. Contrastingly, an unperturbed resident bacterial commensals, limits the colonization of C. albicans in oral mucosa [78]. On the other hand, the virulence of C. albicans can be enhanced through the activation of the proteolytic pathways which is assisted by bacteria like Streptococci sp., contributing to the breach of the oro-mucosal barriers [79]. It is documented that C. albicans competitively and co-operatively survive together with 300 or more bacterial species and through these associations, adhesion and colonization is promoted onto the host tissues [80]. A four category principle is thus finally documented to explain the fungal-bacterial cross-kingdom interactions, where, as an initial step a synergistic role is played by each kingdom assisting them to colonize or infect. It is followed by the predisposition of the first microbe by the second microbe interacting with the host for its own colonization, and as a third step, the second microbe dominates exhibiting antagonism, finally leading to disease through the addition property [81].
A cross-kingdom mutualism is also observed between S. gordonii and C. albicans where the former aids in the persistence of the later and the later provides a reduced oxygen tension for the S. gordonii to grow. The nutrient by-products of the bacterium helps in enhancing the formation of the hyphal filaments of C. albicans with a huge number of interactive signals and additional grow factors or catabolites playing behind the cellular interactions in promoting synergy in this inter-kingdom partnership [82].
7. Immunity and genetics behind the modulations in the oral microbiome
Interleukins and other cytokines play a vital role in shaping the oral microbiome barrier interacting between the microbes and the host immunity. Among various cytokines, IL-17 is considered as the sentinel breaching the mucosal barrier through multiple mechanisms. It also contains the microbial pathogens at the barrier sites and are strategically positioned at various barrier sites preventing infections [83]. In mucosal associated immunity, IL-17 is known to enhance the production of reactive oxygen species and helps in the development of neutrophils in concert with the increase of GM-CSF modulating lymphocyte differentiations too [84]. Cytokines also do immune-surveillance and induces antimicrobial chemotactic factors in co-ordination with other cytokines like IL-22 and are known to induce substances like β-defensins, cathelicidins, lactoferrin etc., [85]. Cytokines are known to interact both under normal and critical physiological and pathological conditions in balancing the normal flora rendering mucosal homeostasis [86].
Examination on the saliva and supra-gingival plaque using the genome wide association studies had documented the host genetics playing a significant role showing similarity in the oral microbiomes of genetically related cases. Heritability also plays a vital role in influencing the bacterial adhesions, with mucins acting as energy sources, and specific immune molecules regulating the bacterial compositions to maintain colonization. Heritability is also associated with the taste receptors determining the dietary preference that can indirectly alter the oral microbiome and the salivary flow rate assisting the same [87]. Many species seem to be heritable, with Aggregatibacter and Leptotrichia sp., to be more heritable and mostly the oral taxa that are heritable tend to lie on the periphery rather than co-occurring with each other [88]. A higher abundance of Prevotella pallens was evident in patients without dental caries and most of the heritable taxa are highly influenced by host genetic factors involving various genes and associated mutations as well [89].
8. Oral microbiome and disease
Amidst the symbiosis and commensalism exhibited by the oral biomes in health, perturbation of an inflammatory response occurs in disease conditions, leading to formation of the pathobionts. Periodontitis and caries are two such disease conditions of the oral cavity that is often established by the increased numbers of these pathobionts dominating the oral commensals [90]. Apart from the inflammatory conditions, there are spurring documents evidencing the association of the oral microbiome with the non-communicable diseases like diabetes, obesity and cancers [91]. Various metagenomic, sequencing and other advanced molecular studies have characterized the variations of the microbiome of the plaque samples from periodontitis cases from healthy controls displaying unique biomes [92]. In the same line, the microbiome of the tongue, palatine, and mucosa of HIV patients, have revealed the enriched symbionts and pathobionts and their unique interactions in both disease and healthy conditions [93]. The vital niches of different study population show majority of bacteriomes with less significance of mycobiomes [94]. These literatures substantiates, that considerable redundancy prevails among the oral microbiome with specific phylogenetic diversity in health and disease conditions.
9. Unraveling the oralomes towards a paradigm shift in therapeutics
A vivid understanding of the oral microbiome, its dysbiosis in disease condition and its interactions with the host, would explore various specific novel therapeutic targets. In this context, many antimicrobial peptides of the oral microbiome have been documented to act against the potential pathogens associated with cancers [95]. Prebiotic and probiotic approach is also a novel research arena that can efficiently modulate the oral microbiome both in health and disease conditions [96]. Genome wide studies revealing the genetic and epigenetic modulations in the oral microbiome is yet another milestone towards targeted therapy of oro-mucosal diseases. “Epidrugs” garner the significant research area ameliorating the effect of disease associated epigenetic proteins such as the bromodomain motif proteins in potential periodontal pathogen P.gingivalis [97]. The association of the oral microbiome with the life-style disorders also have transformed them as potential targets, in improving the physical health of humans. The dynamics of the integrated microbiological and clinical studies will thus comprehensively may explore many regulatory pathways, revealing potential diagnostic and therapeutic targets.
10. Conclusion and perspectives
The cosmos of the oral microbiome is maintained by the significant role played by various microbial kingdoms and cross-reacting species. The most unrevealed virome, mycobiome, oral protozoa and archaeome seem to be the vital part of the oral microbiome, prominently balancing the oral homeostasis in both oral health and oro-dental diseases. The potential involvement of the different microbiome is yet to be explored due to the limitations in the availability of numerous methodological approaches. A better comprehension is thus needed to report on the diversified presence of each kingdom in determining the specific domain of the oral microbiome in different niches of the oral cavity under different conditions.
Declaration of Competing Interest
The authors declare that there is no conflict of interest.
Acknowledgement
The authors are grateful for the management of Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS) for the support in construing the manuscript.
References
- 1.Dewhirst F.E., Chen T., Izard J., Paster B.J., Tanner A.C., Yu W.H., et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002–5017. doi: 10.1128/JB.00542-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lederberg J., Mccray A.T. Ome sweet ’omics—a genealogical treasury of words. Scientist. 2001;15:8–10. [Google Scholar]
- 3.Seymour G.J., Ford P.J., Cullinan M.P., Leishman S., Yamazaki K. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect. 2007;13(4):3–10. doi: 10.1111/j.1469-0691.2007.01798.x. [DOI] [PubMed] [Google Scholar]
- 4.Jenkinson H.F., Lamont R.J. Oral microbial communities in sickness and in health. Trends Microbiol. 2005;13(12):589–595. doi: 10.1016/j.tim.2005.09.006. [DOI] [PubMed] [Google Scholar]
- 5.Hugerth L.W., Seifert M., Pennhag A.A.L., Du J., Hamsten M.C., Schuppe-Koistinen I. A comprehensive automated pipeline for human microbiome sampling,16 S rRNA gene sequencing and bioinformatics processing. BioRxiv. 2018;286526 [Google Scholar]
- 6.Marsh P.D. Dental plaque: biological significance of a biofilm and community life-style. J Clin Periodontol. 2005;32(6):7–15. doi: 10.1111/j.1600-051X.2005.00790.x. [DOI] [PubMed] [Google Scholar]
- 7.Paster B.J., Olsen I., Aas J.A., Dewhirst F.E. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000. 2006;42:80–87. doi: 10.1111/j.1600-0757.2006.00174.x. [DOI] [PubMed] [Google Scholar]
- 8.Knight R., Vrbanac A., Taylor B.C., Aksenov A., Callewaert C., Debelius J., et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16(7):410–422. doi: 10.1038/s41579-018-0029-9. [DOI] [PubMed] [Google Scholar]
- 9.He X., McLean J.S., Edlund A., Yooseph S., Hall A.P., Liu S.Y., et al. Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle. Proc Natl Acad Sci U S A. 2015;112(1):244–249. doi: 10.1073/pnas.1419038112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tian J., Utter D.R., Cen L., Dong P.T., Shi W., Bor B., et al. Acquisition of the arginine deiminase system benefits epiparasitic Saccharibacteria and their host bacteria in a mammalian niche environment. Proc Natl Acad Sci U S A. 2022;119(2) doi: 10.1073/pnas.2114909119. e2114909119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.McLean J.S., Bor B., Kerns K.A., Liu Q., To T.T., Solden L., et al. Acquisition and adaptation of ultra-small parasitic reduced genome bacteria to mammalian hosts. Cell Rep. 2020;32(3) doi: 10.1016/j.celrep.2020.107939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bor B., Bedree J.K., Shi W., McLean J.S., He X. Saccharibacteria (TM7) in the human oral microbiome. J Dent Res. 2019;98(5):500–509. doi: 10.1177/0022034519831671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nobbs A.H., Jenkinson H.F. Interkingdom networking within the oral microbiome. Microbes Infect. 2015;17(7):484–492. doi: 10.1016/j.micinf.2015.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Baker J.L., Bor B., Agnello M., Shi W., He X. Ecology of the oral microbiome: beyond bacteria. Trends Microbiol. 2017;25(5):362–374. doi: 10.1016/j.tim.2016.12.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Virgin H.W. The virome in mammalian physiology and disease. Cell. 2014;157(1):142–150. doi: 10.1016/j.cell.2014.02.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Miller S., Chiu C. Metagenomic Next-generation sequencing for pathogen detection and identification. In advanced techniques in diagnostic microbiology; Springer Science and Business Media LLC: Berlin/Heidelberg. Germany. 2018:617–632. [Google Scholar]
- 17.Pérez-Brocal V., Moya A. The analysis of the oral DNA virome reveals which viruses are widespread and rare among healthy young adults in Valencia (Spain) PLoS One. 2018;13(2) doi: 10.1371/journal.pone.0191867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kaczorowska J., van der Hoek L. Human anelloviruses: diverse omnipresent and commensal members of the virome. FEMS Microbiol Rev. 2020;44:305–313. doi: 10.1093/femsre/fuaa007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Abeles S.R., Pride D.T. Molecular bases and role of viruses in the human microbiome. J Mol Biol. 2014 25;426(23):3892–3906. doi: 10.1016/j.jmb.2014.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ly M., Abeles S.R., Boehm T.K., Robles-Sikisaka R., Naidu M., Santiago-Rodriguez T., et al. Altered oral viral ecology in association with periodontal disease. mBio. 2014;5(3):e01133–14. doi: 10.1128/mBio.01133-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Pride D.T., Salzman J., Haynes M., Rohwer F., Davis-Long C., White R.A., 3rd, Loomer P., Armitage G.C., Relman D.A. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J. 2012;6(5):915–926. doi: 10.1038/ismej.2011.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yolken R.H., Severance E.G., Sabunciyan S., Gressitt K.L., Chen O., Stallings C., et al. Metagenomic sequencing indicates that the oropharyngeal phageome of individuals with schizophrenia differs from that of controls. Schizophr Bull. 2015;41(5):1153–1161. doi: 10.1093/schbul/sbu197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Barr J.J. A bacteriophages journey through the human body. Immunol Rev. 2017;279(1):106–122. doi: 10.1111/imr.12565. [DOI] [PubMed] [Google Scholar]
- 24.Robles-Sikisaka R., Ly M., Boehm T., Naidu M., Salzman J., Pride D.T. Association between living environment and human oral viral ecology. ISME J. 2013;7(9):1710–1724. doi: 10.1038/ismej.2013.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Abeles S.R., Ly M., Santiago-Rodriguez T.M., Pride D.T. Effects of long term antibiotic therapy on human oral and fecal viromes. PLoS One. 2015;10(8) doi: 10.1371/journal.pone.0134941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Willner D., Furlan M., Schmieder R., Grasis J.A., Pride D.T., Relman D.A., et al. Metagenomic detection of phage-encoded platelet-binding factors in the human oral cavity. Proc Natl Acad Sci U S A. 2011;108:4547–4553. doi: 10.1073/pnas.1000089107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Edlund A., Santiago-Rodriguez T.M., Boehm T.K., Pride D.T. Bacteriophage and their potential roles in the human oral cavity. J Oral Microbiol. 2015;7:27423. doi: 10.3402/jom.v7.27423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.de la Cruz Peña M.J., Martinez-Hernandez F., Garcia-Heredia I., Lluesma Gomez M., Fornas Ò., Martinez-Garcia M. Deciphering the human virome with single-virus genomics and metagenomics. Viruses. 2018;10(3):113. doi: 10.3390/v10030113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Gao L., Kang M., Zhang M.J., Reza Sailani M., Kuraji R., Martinez A., et al. Polymicrobial periodontal disease triggers a wide radius of effect and unique virome. NPJ Biofilms Microbiomes. 2020;6(1):10. doi: 10.1038/s41522-020-0120-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ho S.X., Min N., Wong E.P.Y., Chong C.Y., Chu J.J.H. Characterization of oral virome and microbiome revealed distinctive microbiome disruptions in paediatric patients with hand, foot and mouth disease. NPJ Biofilms Microbiomes. 2021;7(1):19. doi: 10.1038/s41522-021-00190-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Liang G., Bushman F.D. The human virome: assembly, composition and host interactions. Nat Rev Microbiol. 2021;19(8):514–527. doi: 10.1038/s41579-021-00536-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ghannoum M.A., Jurevic R.J., Mukherjee P.K., Cui F., Sikaroodi M., Naqvi A., et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6(1) doi: 10.1371/journal.ppat.1000713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.O’Connell L.M., Santos R., Springer G., Burne R.A., Nascimento M.M., Richards V.P. Site-specific profiling of the dental mycobiome reveals strong taxonomic shifts during progression of early-childhood caries. Appl Environ Microbiol. 2020;86(7):e02825–19. doi: 10.1128/AEM.02825-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hong B.Y., Hoare A., Cardenas A., Dupuy A.K., Choquette L., Salner A.L., et al. The salivary mycobiome contains 2 ecologically distinct mycotypes. J Dent Res. 2020;99(6):730–738. doi: 10.1177/0022034520915879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Diaz P.I., Dongari-Bagtzoglou A. Critically appraising the significance of the oral mycobiome. J Dent Res. 2021;100(2):133–140. doi: 10.1177/0022034520956975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ward T.L., Dominguez-Bello M.G., Heisel T., Al-Ghalith G., Knights D., Gale C.A. Development of the human mycobiome over the first month of life and across body sites. mSystems. 2018;3(3):e00140–17. doi: 10.1128/mSystems.00140-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Zakaria M.N., Furuta M., Takeshita T., Shibata Y., Sundari R., Eshima N., et al. Oral mycobiome in community-dwelling elderly and its relation to oral and general health conditions. Oral Dis. 2017;23(7):973–982. doi: 10.1111/odi.12682. [DOI] [PubMed] [Google Scholar]
- 38.Hingston C.D., Hingston E.J., Wise M.P. Impact of nystatin on Candida and the oral microbiome. Crit Care. 2012;16(4):440. doi: 10.1186/cc11360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Baraniya D., Chen T., Nahar A., Alakwaa F., Hill J., Tellez M., et al. Supragingival mycobiome and inter-kingdom interactions in dental caries. J Oral Microbiol. 2020;12(1):1729305. doi: 10.1080/20002297.2020.1729305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Sodré C.S., Rodrigues P.M.G., Vieira M.S., Marques Paes da Silva A., Gonçalves L.S., Ribeiro M.G., et al. Oral mycobiome identification in atopic dermatitis, leukemia, and HIV patients - a systematic review. J Oral Microbiol. 2020;12(1):1807179. doi: 10.1080/20002297.2020.1807179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Annavajhala M.K., Khan S.D., Sullivan S.B., Shah J., Pass L., Kister K., et al. Oral and gut microbial diversity and immune regulation in patients with HIV on antiretroviral therapy. mSphere. 2020;5(1):e00798–19. doi: 10.1128/mSphere.00798-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Willis J.R., Iraola-Guzmán S., Saus E., Ksiezopolska E., Cozzuto L., Bejarano L.A., et al. Oral microbiome in down syndrome and its implications on oral health. J Oral Microbiol. 2020;13(1):1865690. doi: 10.1080/20002297.2020.1865690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Azevedo M.J., Pereira M.L., Araujo R., Ramalho C., Zaura E., Sampaio-Maia B. Influence of delivery and feeding mode in oral fungi colonization - a systematic review. Microb Cell. 2020;7(2):36–45. doi: 10.15698/mic2020.02.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Azzam S.Z., Cayme G.J., Martinez L.R. Polymicrobial interactions involving fungi and their importance for the environment and in human disease. Microb Pathog. 2020;140 doi: 10.1016/j.micpath.2019.103942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Bandara H.M.H.N., Panduwawala C.P., Samaranayake L.P. Biodiversity of the human oral mycobiome in health and disease. Oral Dis. 2019;25(2):363–371. doi: 10.1111/odi.12899. [DOI] [PubMed] [Google Scholar]
- 46.Stehlikova Z., Tlaskal V., Galanova N., Roubalova R., Kreisinger J., Dvorak J., et al. Oral microbiota composition and antimicrobial antibody response in patients with recurrent aphthous stomatitis. Microorganisms. 2019;7(12):636. doi: 10.3390/microorganisms7120636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Hager C.L., Ghannoum M.A. The mycobiome in HIV. Curr Opin HIV AIDS. 2018;13(1):69–72. doi: 10.1097/COH.0000000000000432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Klimesova K., Jiraskova Zakostelska Z., Tlaskalova-Hogenova H. Oral bacterial and fungal microbiome impacts colorectal carcinogenesis. Front Microbiol. 2018;9:774. doi: 10.3389/fmicb.2018.00774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Horz H.P., Conrads G. Methanogenic Archaea and oral infections - ways to unravel the black box. J Oral Microbiol. 2011:3. doi: 10.3402/jom.v3i0.5940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Pausan M.R., Csorba C., Singer G., Till H., Schöpf V., Santigli E., et al. Exploring the archaeome: detection of archaeal signatures in the human body. Front Microbiol. 2019;10:2796. doi: 10.3389/fmicb.2019.02796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Lepp P.W., Brinig M.M., Ouverney C.C., Palm K., Armitage G.C., Relman D.A., Methanogenic Archaea and human periodontal disease. Proc Natl Acad Sci U S A. 2004;101(16):6176–6181. doi: 10.1073/pnas.0308766101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Ferrari A., Brusa T., Rutili A., et al. Isolation and characterization ofMethanobrevibacter oralis sp. nov. Curr Microbiol. 1994;29:7–12. [Google Scholar]
- 53.Diaz P.I. Subgingival fungi, Archaea, and viruses under the omics loupe. Periodontol 2000. 2021;85(1):82–89. doi: 10.1111/prd.12352. [DOI] [PubMed] [Google Scholar]
- 54.Horz H.P., Seyfarth I., Conrads G. McrA and 16S rRNA gene analysis suggests a novel lineage of Archaea phylogenetically affiliated with Thermoplasmatales in human subgingival plaque. Anaerobe. 2012;18(3):373–377. doi: 10.1016/j.anaerobe.2012.04.006. [DOI] [PubMed] [Google Scholar]
- 55.Ashok N., Warad S., Singh V.P., Chaudhari H., Narayanan A., Rodrigues J. Prevalence of archaea in chronic periodontitis patients in an Indian population. Indian J Dent Res. 2013;24(3):289–293. doi: 10.4103/0970-9290.117988. [DOI] [PubMed] [Google Scholar]
- 56.Grine G., Terrer E., Boualam M.A., Aboudharam G., Chaudet H., Ruimy R., Drancourt M. Tobacco-smoking-related prevalence of methanogens in the oral fluid microbiota. Sci Rep. 2018;8(1):9197. doi: 10.1038/s41598-018-27372-7. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 57.Faveri M., Gonçalves L.F., Feres M., Figueiredo L.C., Gouveia L.A., Shibli J.A., et al. Prevalence and microbiological diversity of Archaea in peri-implantitis subjects by 16S ribosomal RNA clonal analysis. J Periodontal Res. 2011;46(3):338–344. doi: 10.1111/j.1600-0765.2011.01347.x. [DOI] [PubMed] [Google Scholar]
- 58.Belkacemi S., Mazel A., Tardivo D., Tavitian P., Stephan G., Bianca G., et al. Peri-implantitis-associated methanogens: a preliminary report. Sci Rep. 2018;8(1):9447. doi: 10.1038/s41598-018-27862-8. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 59.Brusa T., Conca R., Ferrara A., Ferrari A., Pecchioni A. The presence of methanobacteria in human subgingival plaque. J Clin Periodontol. 1987;14(8):470–471. doi: 10.1111/j.1600-051x.1987.tb02254.x. [DOI] [PubMed] [Google Scholar]
- 60.Mansfield J.M., Campbell J.H., Bhandari A.R., Jesionowski A.M., Vickerman M.M. Molecular analysis of 16S rRNA genes identifies potentially periodontal pathogenic bacteria and archaea in the plaque of partially erupted third molars. J Oral Maxillofac Surg. 2012;70(7):1507–1514. doi: 10.1016/j.joms.2011.09.049. e1-6. [DOI] [PubMed] [Google Scholar]
- 61.Vianna M.E., Conrads G., Gomes B.P., Horz H.P. T-RFLP-based mcrA gene analysis of methanogenic archaea in association with oral infections and evidence of a novel Methanobrevibacter phylotype. Oral Microbiol Immunol. 2009;24(5):417–422. doi: 10.1111/j.1399-302X.2009.00539.x. [DOI] [PubMed] [Google Scholar]
- 62.Efenberger M., Agier J., Pawłowska E., Brzezińska-Błaszczyk E. Archaea prevalence in inflamed pulp tissues. Cent Eur J Immunol. 2015;40(2):194–200. doi: 10.5114/ceji.2015.51358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Dame-Teixeira N., de Cena J.A., Côrtes D.A., Belmok A., Dos Anjos Borges L.G., Marconatto L., Giongo A., Kyaw C.M. Presence of Archaea in dental caries biofilms. Arch Oral Biol. 2020;110 doi: 10.1016/j.archoralbio.2019.104606. [DOI] [PubMed] [Google Scholar]
- 64.Ziesemer K.A., Mann A.E., Sankaranarayanan K., Schroeder H., Ozga A.T., Brandt B.W. Intrinsic challenges in ancient microbiome reconstruction using 16S rRNA gene amplification. Sci Rep. 2015;5:16498. doi: 10.1038/srep16498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Philips A., Stolarek I., Kuczkowska B., Juras A., Handschuh L., Piontek J., Kozlowski P., Figlerowicz M. Comprehensive analysis of microorganisms accompanying human archaeological remains. Gigascience. 2017;6(7):1–13. doi: 10.1093/gigascience/gix044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Huynh H.T., Nkamga V.D., Signoli M., Tzortzis S., Pinguet R., Audoly G., Aboudharam G., Drancourt M. Restricted diversity of dental calculus methanogens over five centuries, France. Sci Rep. 2016;6:25775. doi: 10.1038/srep25775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Willis J.R., Gabaldón T. The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms. 2020;8(2):308. doi: 10.3390/microorganisms8020308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Yaseen A., Mahafzah A., Dababseh D., Taim D., Hamdan A.A., Al-Fraihat E., et al. Oral colonization by entamoeba gingivalis and trichomonas tenax: a PCR-based study in health, gingivitis, and periodontitis. Front Cell Infect Microbiol. 2021;11 doi: 10.3389/fcimb.2021.782805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Cielecka D., Chomicz L., Piekarczyk J., Walski M., Zawadzki P.J., Bednarczyk A., et al. Oral cavity condition and the occurrence of parasitic protozoans in patients with genetic diseases. Acta Parasitologica. 2000;45:107–112. [Google Scholar]
- 70.Feki A., Molet B., Haag R., Kremer M. Les protozoaires de la cavité buccale humaine (corrélations épidémiologiques et possibilités pathogéniques) [Protozoa of the human oral cavity (epidemiological correlations and pathogenic possibilities] J Biol Buccale. 1981;9(2):155–161. [PubMed] [Google Scholar]
- 71.Wantland W.W., Wantland E.M., Remo J.W., Winquist D.L. Studies on human mouth protozoa. J Dent Res. 1958;37(5):949–950. doi: 10.1177/00220345580370052601. [DOI] [PubMed] [Google Scholar]
- 72.He J., Li Y., Cao Y., Xue J., Zhou X. The oral microbiome diversity and its relation to human diseases. Folia Microbiol (Praha) 2015;60(1):69–80. doi: 10.1007/s12223-014-0342-2. [DOI] [PubMed] [Google Scholar]
- 73.Van Belleghem J.D., Dąbrowska K., Vaneechoutte M., Barr J.J., Bollyky P.L. Interactions between bacteriophage, bacteria, and the mammalian immune system. Viruses. 2018;11(1):10. doi: 10.3390/v11010010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Khelaifia S., Lagier J.C., Nkamga V.D., Guilhot E., Drancourt M., Raoult D. Aerobic culture of methanogenic archaea without an external source of hydrogen. Eur J Clin Microbiol Infect Dis. 2016;35(6):985–991. doi: 10.1007/s10096-016-2627-7. [DOI] [PubMed] [Google Scholar]
- 75.Seedorf H., Dreisbach A., Hedderich R., Shima S., Thauer R.K. F420H2 oxidase (FprA) from Methanobrevibacter arboriphilus, a coenzyme F420-dependent enzyme involved in O2 detoxification. Arch Microbiol. 2004;182(2–3):126–137. doi: 10.1007/s00203-004-0675-3. [DOI] [PubMed] [Google Scholar]
- 76.Robichaux M., Howell M., Boopathy R. Methanogenic activity in human periodontal pocket. Curr Microbiol. 2003;46(1):53–58. doi: 10.1007/s00284-002-3807-5. [DOI] [PubMed] [Google Scholar]
- 77.Horz H.P., Robertz N., Vianna M.E., Henne K., Conrads G. Relationship between methanogenic archaea and subgingival microbial complexes in human periodontitis. Anaerobe. 2015;35(Pt A):10–12. doi: 10.1016/j.anaerobe.2015.02.008. [DOI] [PubMed] [Google Scholar]
- 78.Ranjan A., Dongari-Bagtzoglou A. Tipping the balance: C. albicans adaptation in polymicrobial environments. J Fungi (Basel) 2018;4(3):112. doi: 10.3390/jof4030112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Bertolini M., Dongari-Bagtzoglou A. The dysbiosis and inter-kingdom synergy model in oropharyngeal candidiasis, a new perspective in pathogenesis. J Fungi (Basel) 2019;5(4):87. doi: 10.3390/jof5040087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.He Y., Gong D., Shi C., Shao F., Shi J., Fei J. Dysbiosis of oral buccal mucosa microbiota in patients with oral lichen planus. Oral Dis. 2017;23(5):674–682. doi: 10.1111/odi.12657. [DOI] [PubMed] [Google Scholar]
- 81.Krüger W., Vielreicher S., Kapitan M., Jacobsen I.D., Niemiec M.J. Fungal-bacterial interactions in health and disease. Pathogens. 2019;8(2):70. doi: 10.3390/pathogens8020070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Bamford C.V., d'Mello A., Nobbs A.H., Dutton L.C., Vickerman M.M., Jenkinson H.F. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect Immun. 2009;77(9):3696–3704. doi: 10.1128/IAI.00438-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010;10(7):479–489. doi: 10.1038/nri2800. [DOI] [PubMed] [Google Scholar]
- 84.O'Connor W., Jr, Kamanaka M., Booth C.J., Town T., Nakae S., Iwakura Y., et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009;10(6):603–609. doi: 10.1038/ni.1736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Peric M., Koglin S., Kim S.M., Morizane S., Besch R., Prinz J.C., et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol. 2008;181(12):8504–8512. doi: 10.4049/jimmunol.181.12.8504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Abusleme L., Moutsopoulos N.M. IL-17: overview and role in oral immunity and microbiome. Oral Dis. 2017;23(7):854–865. doi: 10.1111/odi.12598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Davenport E.R. Tooth be told, genetics influences oral microbiome. Cell Host Microbe. 2017;22(3):251–253. doi: 10.1016/j.chom.2017.08.018. [DOI] [PubMed] [Google Scholar]
- 88.Gomez A., Espinoza J.L., Harkins D.M., Leong P., Saffery R., Bockmann M., et al. Host genetic control of the oral microbiome in health and disease. Cell Host Microbe. 2017;22(3):269–278. doi: 10.1016/j.chom.2017.08.013. e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Goodrich J.K., Davenport E.R., Waters J.L., Clark A.G., Ley R.E. Cross-species comparisons of host genetic associations with the microbiome. Science. 2016;352(6285):532–535. doi: 10.1126/science.aad9379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Wade W.G. The oral microbiome in health and disease. Pharmacol Res. 2013;69(1):137–143. doi: 10.1016/j.phrs.2012.11.006. [DOI] [PubMed] [Google Scholar]
- 91.Lu Maoyang, Xuan Songyu, Wang Zhao. Oral microbiota: a new view of body health. Food Science and Human Wellness. 2019;8(1):8–15. [Google Scholar]
- 92.Abusleme L., Dupuy A.K., Dutzan N., Silva N., Burleson J.A., Strausbaugh L.D., et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 2013;7(5):1016–1025. doi: 10.1038/ismej.2012.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Lu H., Ren Z., Li A., Li J., Xu S., Zhang H., et al. Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls. J Oral Microbiol. 2019;11(1):1563409. doi: 10.1080/20002297.2018.1563409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Fukui Y., Aoki K., Ishii Y., Tateda K. The palatine tonsil bacteriome, but not the mycobiome, is altered in HIV infection. BMC Microbiol. 2018;18(1):127. doi: 10.1186/s12866-018-1274-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Shin J.M., Ateia I., Paulus J.R., Liu H., Fenno J.C., Rickard A.H., et al. Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells. Front Microbiol. 2015;6:617. doi: 10.3389/fmicb.2015.00617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Radaic A., Ganther S., Kamarajan P., Grandis J., Yom S.S., Kapila Y.L. Paradigm shift in the pathogenesis and treatment of oral cancer and other cancers focused on the oralome and antimicrobial-based therapeutics. Periodontol. 2000;87(1):76–93. doi: 10.1111/prd.12388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Maksylewicz A., Bysiek A., Lagosz K.B., Macina J.M., Kantorowicz M., Bereta G., et al. BET Bromodomain Inhibitors Suppress Inflammatory Activation of Gingival Fibroblasts and Epithelial Cells From Periodontitis Patients. Front Immunol. 2019;10:933. doi: 10.3389/fimmu.2019.00933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Zhu J., Tian L., Chen P., Han M., Song L., Tong X., et al. Over 50,000 metagenomically assembled draft genomes for the human oral microbiome reveal new taxa. Genomics Proteomics Bioinformatics. 2021;S1672–0229(21) doi: 10.1016/j.gpb.2021.05.001. 00176-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Belda-Ferre P., Alcaraz L.D., Cabrera-Rubio R., Romero H., Simón-Soro A., Pignatelli M., Mira A. The oral metagenome in health and disease. ISME J. 2012;6(1):46–56. doi: 10.1038/ismej.2011.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Wang Y., Zhang J., Chen X., Jiang W., Wang S., Xu L., et al. Profiling of oral microbiota in early childhood caries using single-molecule real-time sequencing. Front Microbiol. 2017;8:2244. doi: 10.3389/fmicb.2017.02244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Chen T., Yu W.H., Izard J., Baranova O.V., Lakshmanan A., Dewhirst F.E. The human oral microbiome database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford) 2010;2010 doi: 10.1093/database/baq013. baq013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Wang Y., Wang S., Wu C., Chen X., Duan Z., Xu Q., et al. Oral microbiome alterations associated with early childhood caries highlight the importance of carbohydrate metabolic activities. mSystems. 2019;4(6):e00450–19. doi: 10.1128/mSystems.00450-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Ma S., Zhang F., Zhou F., Li H., Ge W., Gan R. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19. Signal Transduct Target Ther. 2021;6(1):191. doi: 10.1038/s41392-021-00614-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Abeles S.R., Robles-Sikisaka R., Ly M., Lum A.G., Salzman J., Boehm T.K., et al. Human oral viruses are personal, persistent and gender-consistent. ISME J. 2014;8(9):1753–1767. doi: 10.1038/ismej.2014.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Yahara K., Suzuki M., Hirabayashi A., Suda W., Hattori M., Suzuki Y., et al. Long-read metagenomics using PromethION uncovers oral bacteriophages and their interaction with host bacteria. Nat Commun. 2021;12(1):27. doi: 10.1038/s41467-020-20199-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Peters B.A., Wu J., Hayes R.B., Ahn J. The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study. BMC Microbiol. 2017;17(1):157. doi: 10.1186/s12866-017-1064-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Li Y., Wang K., Zhang B., Tu Q., Yao Y., Cui B., et al. Salivary mycobiome dysbiosis and its potential impact on bacteriome shifts and host immunity in oral lichen planus. Int J Oral Sci. 2019;11(2):13. doi: 10.1038/s41368-019-0045-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Fechney J.M., Browne G.V., Prabhu N., Irinyi L., Meyer W., Hughes T., et al. Preliminary study of the oral mycobiome of children with and without dental caries. J Oral Microbiol. 2018;11(1):1536182. doi: 10.1080/20002297.2018.1536182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Shigeishi H., Sugiyama M., Ohta K., Yokoyama S., Sakuma M., Murozumi H., Kato H., Takechi M. High HPV16 E6 viral load in the oral cavity is associated with an increased number of bacteria: A preliminary study. Biomed Rep. 2018;8(1):59–64. doi: 10.3892/br.2017.1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Mayer B.T., Matrajt L., Casper C., Krantz E.M., Corey L., Wald A., et al. Dynamics of persistent oral cytomegalovirus shedding during primary infection in ugandan infants. J Infect Dis. 2016;214(11):1735–1743. doi: 10.1093/infdis/jiw442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Mukherjee P.K., Chandra J., Retuerto M., Sikaroodi M., Brown R.E., Jurevic R., et al. Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi. PLoS Pathog. 2014;10(3) doi: 10.1371/journal.ppat.1003996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Niemiec B.A., Gawor J., Tang S., Prem A., Krumbeck J.A. The mycobiome of the oral cavity in healthy dogs and dogs with periodontal disease. Am J Vet Res. 2021;83(1):42–49. doi: 10.2460/ajvr.20.11.0200. [DOI] [PubMed] [Google Scholar]
- 113.Krumbeck J.A., Reiter A.M., Pohl J.C., Tang S., Kim Y.J., Linde A., et al. Characterization of oral microbiota in cats: novel insights on the potential role of fungi in feline chronic gingivostomatitis. Pathogens. 2021;10(7):904. doi: 10.3390/pathogens10070904. [DOI] [PMC free article] [PubMed] [Google Scholar]